Cargando...
Pharmacogenomics of hepatitis C infections: personalizing therapy
It is a widely held view that drug response genes have not proved as useful in clinical practice as anticipated at the start of the genomic era. An exception is in the treatment for chronic hepatitis C virus (HCV) genotype 1 infection with pegylated interferon α and ribavirin. In 2009, four independ...
Gardado en:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
BioMed Central
2012
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3580439/ https://ncbi.nlm.nih.gov/pubmed/23268841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm400 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|